Endocannabinoids effective in treating Parkinson's
Marijuana-like chemicals in the brain may point to a treatment for Parkinson's disease. In a study to be published in the February 8 issue of Nature, researchers from the Stanford University School of Medicine report that endocannabinoids, naturally occurring chemicals found in the brain that are similar to the active compounds in marijuana and hashish, helped trigger a dramatic improvement in mice with a condition similar to Parkinson's.
"The dopamine drug alone did a little bit but it wasn't great, and the drug that targeted the enzyme that degrades endocannabinoids basically did nothing alone," said Anatol Kreitzer at Stanford University school of medicine. "But when we gave the two together, the animals really improved dramatically."
- here's a report on the research from The Guardian
- and here's the release
Related Articles:
Marijuana may help prevent Alzheimer's. Report
Comments
Post new comment
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight

